Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ASLN |
---|---|---|
09:32 ET | 3371 | 0.37 |
09:50 ET | 11515 | 0.3598 |
09:52 ET | 1943 | 0.35 |
09:54 ET | 2122 | 0.3455 |
09:56 ET | 41823 | 0.335 |
09:57 ET | 10373 | 0.333745 |
09:59 ET | 1800 | 0.335 |
10:01 ET | 1800 | 0.335 |
10:08 ET | 1700 | 0.34 |
10:10 ET | 19788 | 0.3335 |
10:12 ET | 8369 | 0.334 |
10:14 ET | 4000 | 0.333 |
10:15 ET | 15771 | 0.3334 |
10:17 ET | 1316 | 0.33305 |
10:19 ET | 100 | 0.3331 |
10:26 ET | 200 | 0.3335 |
10:32 ET | 9325 | 0.335 |
10:35 ET | 1200 | 0.3399 |
10:39 ET | 10100 | 0.335 |
10:42 ET | 400 | 0.3336 |
10:44 ET | 300 | 0.3332 |
10:46 ET | 1284 | 0.3332 |
10:50 ET | 600 | 0.3334 |
10:51 ET | 100 | 0.3335 |
10:55 ET | 350 | 0.334101 |
11:04 ET | 9829 | 0.333 |
11:09 ET | 9168 | 0.331 |
11:11 ET | 29528 | 0.326 |
11:13 ET | 200 | 0.326 |
11:18 ET | 2200 | 0.322 |
11:20 ET | 2320 | 0.321 |
11:27 ET | 100 | 0.322 |
11:31 ET | 10000 | 0.3259 |
11:33 ET | 700 | 0.3259 |
11:36 ET | 25300 | 0.322 |
11:38 ET | 107 | 0.32205 |
11:47 ET | 13834 | 0.326 |
11:51 ET | 400 | 0.3229 |
11:58 ET | 1802 | 0.3222 |
12:00 ET | 800 | 0.331101 |
12:03 ET | 500 | 0.333 |
12:18 ET | 300 | 0.3399 |
12:39 ET | 6767 | 0.3222 |
12:43 ET | 250 | 0.3279 |
01:03 ET | 100 | 0.3328 |
01:08 ET | 10499 | 0.3394 |
01:10 ET | 600 | 0.333 |
01:17 ET | 200 | 0.3301 |
01:24 ET | 278 | 0.332 |
01:28 ET | 100 | 0.3301 |
01:32 ET | 13164 | 0.3266 |
01:33 ET | 1000 | 0.3238 |
01:37 ET | 400 | 0.32695 |
01:39 ET | 100 | 0.3279 |
01:50 ET | 200 | 0.3266 |
01:55 ET | 100 | 0.3298 |
02:02 ET | 502 | 0.327951 |
02:04 ET | 750 | 0.326001 |
02:09 ET | 100 | 0.3279 |
02:11 ET | 500 | 0.3299 |
02:13 ET | 3166 | 0.316 |
02:15 ET | 200 | 0.318 |
02:18 ET | 1500 | 0.3199 |
02:29 ET | 11919 | 0.3111 |
02:31 ET | 100 | 0.3112 |
02:33 ET | 1955 | 0.3102 |
02:58 ET | 7437 | 0.3197 |
03:03 ET | 16981 | 0.3121 |
03:09 ET | 5000 | 0.31969 |
03:25 ET | 4200 | 0.3196 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Aslan Pharmaceuticals Ltd | 8.1M | -0.1x | --- |
NuCana PLC | 6.3M | 0.0x | --- |
Weed Inc | 8.5M | -6,700.0x | --- |
Allarity Therapeutics Inc | 7.8M | 0.0x | --- |
National Graphite Corp | 7.7M | -2.3x | --- |
Cyclerion Therapeutics Inc | 7.6M | -0.6x | --- |
ASLAN Pharmaceuticals Limited is a clinical-stage immunology focused biopharmaceutical company. The Company's portfolio is led by eblasakimab (ASLAN004), a potential human monoclonal antibody that binds to the IL-13 receptor a1 subunit (IL-13Ra1), blocking signaling of two pro-inflammatory cytokines, IL-4 and IL-13, which are central to triggering symptoms of atopic dermatitis, such as redness and itching of the skin. It is conducting a Phase II b clinical trial investigating eblasakimab as a therapeutic antibody for moderate-to-severe atopic dermatitis (AD). The Company is also developing farudodstat (ASLAN003), an orally active, potent inhibitor of human dihydroorotate dehydrogenase (DHODH) that has the potential to be a therapy for autoimmune disease. The Company is also focused on developing antagonists of the aryl hydrocarbon receptor (AhR), an immune checkpoint inhibitor, through a joint venture.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.1M |
---|---|
Revenue (TTM) | $12.0M |
Shares Outstanding | 905.1K |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.42 |
EPS | $-3.01 |
Book Value | $3.00 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 0.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -369.02% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.